Total 8 theses and 80 articles.

Theses

Hällsten U. Studies of physical processes generated by energetic ions in dense target gases. Department of Physics, Åbo Akademi, 2003, 42 p.

Janatuinen T. Coronary artery disease risk factors and myocardial blood flow in young adults. With special reference to statin treatment. Doctoral dissertation. Turku: Turun yliopisto, 2003. Annales Universitatis Turkuensis. Series D 567. 84 p.

Järvenpää T. Monozygotic twins and cognitive decline with emphasis on Alzheimer's disease. Doctoral dissertation. Turku: Turun yliopisto, 2003. Annales Universitatis Turkuensis. Series D 570. 76 p.

Järvisalo M. Arterial changes related to early atherosclerosis in children and adolescents. A High-Resolution Ultrasound Study. Doctoral dissertation Turku: Turun yliopisto, 2003. Annales Universitatis Turkuensis. Series D 560, 94 p.

Kemppainen J. Skeletal muscle metabolism and perfusion in healthy men and patients with dilated cardomyopathy. With special reference to the effects of training. Doctoral dissertation. Turku: Turun yliopisto, 2003. Annales Universitatis Turkuensis. Series D 549. 101 p.

Lehtiö K. Imaging Perfusion and Hypoxia in Head and Neck Cancer Using Positron Emission Tomography (PET). Doctoral dissertation. Turku: Turun Yliopisto, 2003. Annales Universitatis Turkuensis. Series D 547. 90 p.

Stolen K. The effects of exercise training on myocardial function and metabolism in patients with idiopathic cardiomyopathy. Studies using positron emission tomography. Doctoral dissertation. Turku: Turun yliopisto, 2003. Annales Universitatis Turkuensis. Series D 562 p.,

Virtanen K. Insulin-stimulated glucose uptake in adipose tissue. Positron emission tomography studies in obesity and type 2 diabetes. Doctoral dissertation. 2003. Annales Universitatis Turkuensis. Series D 540. 89 p.

Articles

*Aaltonen J, *Dendooven P, *Gromova EA, Heselius S-J, *Jakovlev VA, *Trzaska WH. Production of 235Np, 236Pu and 237Pu via nuclear reactions on 235,236,238U and 237Np targets. Radiochimica Acta 2003:91:557-565. IF [0,66]

Aho A, Suominen E, Alanen A, Yli-Urpo A, Knuuti J, Aho H. Remodeling of the tibia after grafting of a large cavity with particulate bioactive glass-hydroxylapatite - case report on treatment of fibrous dysplasia with 13 years' follow up. Acta Orthop Scand 2003:74(6):766-770. IF [1,169]

Bettinardi V, Alenius S, Numminen P, Teräs M, Gilardi MC, Fazio F, Ruotsalainen U. Implementation and evaluation of an ordered subsets reconstruction algorithm for transmission PET studies using median root prior and inter-update median filtering. Eur J Nucl Med 2003:30:222-231. IF [3,464]

*Bergström K, Någren K. Radiolääkkeet. Kirjassa: Sovijärvi A, Ahonen A, Hartiala J, Länsimies E, Savolainen S, Turjanmaa V, Vanninen E, toim. Kliininen fysiologia ja isotooppilääketiede, s. 29-40. Helsinki: Kustannus Oy Duodecim, 2003.

*Brust P, *Zessin J, *Kuwabara H, *Pawelke B, *Kretzschmar M, *Hinz R, Bergman J, Eskola O, Solin O, *Steinbach J, *Johannsen B. Positron emission tomography imaging of the serotonin transporter in the pig brain using (11C)(+)-McN5652 and S-((18F)fluoromethyl)-(+)-McN5652. Synapse 2003:47:143-151. IF [2,631]

*Fujimoto T, Kemppainen J, Kalliokoski K, Nuutila P, *Ito M, Knuuti J. Skeletal muscle glucose uptake response to exercise in trained and untrained men. Med Sci Sports Exerc 2003:35(5):777-783. IF [2,600]

Haaparanta M, Paul R, Grönroos T, Bergman J, *Kämäräinen E-L, Solin O. Microdialysis and 2-(18F)fluoro-2-deoxy-D-glucose (FDG): a study on insulin action on FDG transport, uptake and metabolism in rat muscle, liver and adipose tissue. Life Sci 2003:73:1437-1451. IF [1,824]

Haarala C, Aalto S, *Hautzel H, Julkunen L, Rinne J, Laine M, *Krause B, Hämäläinen H. Effects of a 902 MHz mobile phone on cerebral blood flow in humans: a PET study. Neuroreport 2003:14(16):2019-2023. IF [2,265]

Hagelberg N, Forssell H, Aalto S, Rinne JO, Scheinin H, Taiminen T, Någren K, Eskola O, *Jääskeläinen SK. Altered dopamine D2 receptor binding in atypical facial pain. PAIN 2003:106:43-48. IF [4,829]

Hagelberg N, Forssell H, Rinne JO, Scheinin H, Taiminen T, Aalto S, *Luutonen S, Någren K, *Jääskeläinen S. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. PAIN 2003:101:149-154. IF [4,829]

*Halldin C, Någren K. PET-radiopharmaceuticals - C11 compounds of clinical value. In: Von Schulthess Gustav, ed. Clinical molecular anatomic imaging, 2003:117-120. Lippincott, Williams & Wilkins.

Hallikainen T, Hietala J, Kauhanen J, Pohjalainen T, Syvälahti E, Salonen JT, Tiihonen J. Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males. Am J Med Genet 2003:119A:152-155. IF [2,334]

*Hemling N, Röyttä M, Rinne J, Pöllänen P, *Broberg E, *Tapio V, *Vahlberg T, *Hukkanen V. Herpesviruses in brains in Alzheimer's and Parkinson's disease. Ann Neurol 2003:54:267-271. IF [8,603]

Hietala J, *Cannon T, Syvälahti E, Vilkman H, Laakso A, *Vahlberg T, *Alakare B, *Räkköläinen V, Salokangas R. Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia. Schizophr Res 2003:64:79-81. IF [3,203]

Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, Hagelberg N, Oikonen V, Hietala J. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride. Nucl Med Commun 2003:24:1207-1214. IF [1,19]

Hällsten K, *Yki-Järvinen H, Peltoniemi P, Oikonen V, Takala T, Kemppainen J, Laine H, Bergman J, *Bolli G, Knuuti J, Nuutila P. Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men. Obes Res 2003:11(2):257-265. IF [3,025]

Härkönen K, *Huhtaniemi I, Mäkinen J, *Hübler D, Irjala K, Koskenvuo M, *Oettel M, Raitakari O, *Saad F, Pöllänen P. The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 2003:26:187-194. IF [1,520]

Iozzo P, *Geisler F, Oikonen V, Mäki M, Takala T, Solin O, *Ferrannini E, Knuuti J, Nuutila P. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET study. JOURNAL OF NUCLEAR MEDICINE 2003:44:682-689. IF [4,587]

Iozzo P, Hällsten K, Oikonen V, Virtanen K, Kemppainen J, Solin O, *Ferrannini E, Knuuti J, Nuutila P. Insulin-mediated hepatic glucose uptake is impaired in type 1 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 2003:88(5):2055-2060. IF [5,199]

Iozzo P, Hällsten K, Oikonen V, Virtanen K, *Parkkola R, Kemppainen J, Solin O, *Lönnqvist F, *Ferrannini E, Knuuti J, Nuutila P. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes. Diabetes Care 2003:26:2069-2074. IF [5,477]

Iozzo P, *Turpeinen A, Takala T, Oikonen V, Solin O, *Ferrannini E, Nuutila P, Knuuti J. Liver uptake of free fatty acids in vivo in humans as determined with 14(R,S)-(18F)fluoro-6-thia-heptadecanoic acid and PET. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2003:30(8):1160-1164. IF [3,568]

Janatuinen T, *Laakso J, *Laaksonen R, Vesalainen R, Nuutila P, *Lehtimäki T, Raitakari O, Knuuti J. Plasma asymmetric dimethylarginine modfies the effect of pravastatin on myocardial blood flow in young adults. Vascular Medicine 2003:8:185-189. IF [1,145]

Jartti L, Raitakari OT, *Järvisalo J, *Hammar N, Kaprio J, Koskenvuo M, *Marniemi J, *Saikku P, Rönnemaa T. Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis. Clin Sci 2003:105:303-313. IF [1,941]

*Joensuu H, *Kankaanranta L, *Seppälä T, *Auterinen I, *Kallio M, *Kulvik M, *Laakso J, *Vähätalo J, *Kortesniemi M, *Kotiluoto P, *Serén T, *Karila J, *Brander A, *Järviluoma E, *Ryynänen P, *Paetau A, *Ruokonen I, Minn H, *Tenhunen M, *Jääskeläinen J, *Färkkilä M, *Savolainen S. Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronphenylalanine. J Neurooncol 2003:62:123-134. IF [1,416]

*Johansson B, Sundell J, *Ekberg K, *Jonsson C, *Seppänen M, Raitakari O, Luotolahti M, Nuutila P, *Wahren J, Knuuti j. Proinsulin C-peptide improves adenosine-stimulated myocardial blood flow in type 1 diabetic patients. Am J Physiol Endokrinol Metab 2003:3. IF [3,324]

*Joyal C, *Laakso M, *Tiihonen J, Syvälahti E, Vilkman H, Laakso A, *Alakare B, *Räkköläinen V, Salokangas R, Hietala J. The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients. Biol Psychiatry 2003:54:1302-1304. IF [5,915]

Jyrkkiö S, *Nuutinen J, Minn H. PET-tutkimus syövän hoidon suunnittelussa ja hoitovasteen seurannassa. Suomen Lääkäril 2003:58(7):775-778.

Järvenpää T, Raihä I, Kaprio J, Koskenvuo M, Laine M, Kurki T, Viljanen T, Rinne J. A 90-year-old monozygotic female twin pair discordant for Alzheimer's disease. Neurobiol Aging 2003:24:941-945. IF [6,155]

Järvenpää T, Räihä I, Kaprio J, Koskenvuo M, Laine M, Kurki T, *Vahlberg T, Viljanen T, *Ahonen K, Rinne J. Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease. Dement Geriatr Cogn Disord 2003:16:245-252. IF [2,804]

Järvisalo MJ, Jartti L, Karvonen MK, *Pesonen U, Koulu M, *Marniemi J, *Hammar N, Karpio J, *Pakkunainen U, Simell O, Raitakari OT, Rönnemaa T. Enhanced endothelium-dependent vasodilation in subjects with proline7 substitution in the signal peptide of neuropeptide Y. Atherosclerosis 2003:16:319-326. IF [3,333]

*Jääskeläinen SK, Kaisti K, *Suni L, Hinkka S, Scheinin H. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia. Neurology 2003:61(8):1073-1078. IF [5,340]

Kaasinen V, Aalto S, Någren K, Hietala J, Sonninen P, Rinne J. Extrastriatal dopamine D2 receptors in Parkinson's disease: a longitudinal study. J Neural Transm 2003:110:591-601. IF [1,862]

Kaisti K K, Långsjö J W, Aalto S, Oikonen V, *Sipilä H, *Teräs M, Hinkka S, Metsähonkala L, Scheinin H. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003:99(3):603-613. IF [3,470]

*Kaitosaari T, Rönnemaa T, Raitakari O, *Talvia S, *Kallio K, *Volanen I, *Leino A, *Jokinen E, Välimäki I, Viikari J, Simell O. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized special Turku coronary risk factor intervention project for children (STRIP) study. Circulation 2003:108:672-677. IF [10,255]

Kalliokoski K, *Kuusela T, Laaksonen M, Knuuti J, Nuutila P. Muscle fractal vascular branching pattern and microvascular perfusion heterogeneity in endurance-trained and untrained men. J Physiol (Lond) 2003:546(2):529-535. IF [4,650]

Kalliokoski K, Laaksonen M, Takala T, Knuuti J, Nuutila P. Muscle oxygen extraction and perfusion heterogeneity during continuous and intermittent static exercise. J Appl Physiol 2003:94:953-958. IF [2,720]

Kalliokoski KK, Laaksonen MS, Knuuti J, Nuutila P. Perfusion distribution between and within muscles during intermittent isometric exercise in endurance-trained and untrained men. Int J Sports Med 2003:24:400-403. IF [1,348]

Kemppainen J, Stolen K, Kalliokoski K, Salo T, Karanko H, Viljanen T, Airaksinen J, Nuutila P, Knuuti J. Exercise training improves insulin stimulated skeletal muscle glucose uptake independent of changes in perfusion in patients with dilated cardiomyopathy. J Card Fail 2003:9(4):286-295. IF [2,574]

Kemppainen J, *Tsuchida H, Stolen K, Karlsson H, *Björnholm M, Heinonen O, Nuutila P, *Krook A, Knuuti J, *Zierath J. Insulin signalling and resistance in patients with chronic heart failure. J Physiol (Lond) 2003(550.1):305-315. IF [4,650]

*Kemppainen N, Laine M, *Laakso P, Kaasinen V, Någren K, *Vahlberg T, Kurki T, Rinne J. Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease. Eur J Neurosci 2003:18:149-154. IF [4,163]

Knuuti J. Sydämen toiminnan tutkimukset positroniemissiotomografialla (PET). Kirjassa: Sovijärvi A, Ahonen A, Hartiala J, Länsimies E, Savolainen S, Turjanmaa V, Vanninen E, toim. Kliininen fysiologia ja isotooppilääketiede, s. 413-415. Helsinki: Duodecim Oy, 2003.

Koskenvuo JW, Saraste M, Niemi P, Knuuti J, *Sakuma H, *Toikka JO, *Komu M, Järvisalo MJ, Hartiala JJ. Correlation of transthoracic Doppler echocardiography and magnetic resonance imaging in measuring left anterior descending artery flow velocity and time-course of dipyridamole-induced coronary flow increase. Scand J Clin Lab Invest 2003:63:65-72. IF [0,937]

Laakso A, *Wallius E, Kajander J, Bergman J, Eskola O, Solin O, *Ilonen T, Salokangas RKR, Syvälahti E, Hietala J. Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry 2003:160(5):904-910. IF [6,458]

Laaksonen MS, Kalliokoski KK, *Kyröläinen H, Kemppainen J, *Teräs M, Sipilä H, Nuutila P, Knuuti J. Skeletal muscle blood flow and flow heterogeneity during dynamic and isometric exercise in humans. Am J Physiol Heart Circ Physiol 2003:284:H979-H986. IF [3,369]

*Laatu S, Revonsuo A, *Jäykkä H, Portin R, Rinne JO. Visual object recognition in early Alzheimer´s disease; deficits in semantic processing. Acta Neurol Scand 2003:108:82-89. IF [1,358]

*Langenfeld M, *Simmons L, *McCrohon J, Raitakari O, *Lattimore JD, *Hennessy A, *Celermajer D. Nitric oxide does not mediate the vasodilation of early human pregnancy. HEART, LUNG AND CIRCULATION 2003:12:142-148. IF [0,943]

*Langer O, *Forngren T, *Sandell J, *Dollé F, *Långström B, Någren K, *Halldin C. Preparation of 4-(11C)methylmetaraminol, a potential PET tracer for assessment of myocardial sympathetic innervation. J Labelled Compd & Radiopharm 2003:46:55-65. IF [1,186]

*Lehtimäki T, *Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Mattila K, *Ilveskoski E, *Luomala M, *Saikku P, Knuuti J, Hurme M. Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. Pharmacogenetics 2003:13:633-639. IF [5,540]

Lehtiö K, Oikonen V, Nyman S, Grönroos T, Roivainen A, Eskola O, Minn H. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ((18F)FETNIM) and PET using the tumour to plasma ratio. Eur J Nucl Med 2003:30:101-108. IF [3,464]

Långsjö J, Kaisti K, Aalto S, Hinkka S, Aantaa R, Oikonen V, *Sipilä H, Kurki T, *Silvanto M, Scheinin H. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003:99(3):614-623. IF [3,470]

*MacManus M, *Hicks, R, *Matthews J, *McKenzie A, *Rischin D, Salminen EK, *Ball, D. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2003:21(7):1285-1292. IF [9,868]

Marjamäki P, *Zessin J, Eskola O, Grönroos T, Haaparanta M, Bergman J, Lehikoinen P, Forsback S, *Brust P, *Steinbach J, Solin O. S-(18F)fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats. Synapse 2003:47:45-53. IF [2,631]

Mattila KM, *Hiltunen M, Rinne JO, *Mannermaa A, Röyttä M, *Alafuzoff I, *Laippala P, *Soininen H, *Lehtimäki T. Absence of association between an intercellular adhesion molecule 1 gene E469 polymorphism and Alzheimer's disease in Finnish patients. Neurosci Lett 2003:337:61-63. IF [2,100]

Minn H. Kasvainten PET-kuvaukset. Kirjassa: Sovijärvi A, Ahonen A, Hartiala J, Länsimies E, Savolainen S, Turjanmaa V, Vanninen E, toim. Kliininen fysiologia ja isotooppilääketiede, s. 602-607. Helsinki: Kustannus Oy Duodecim, 2003.

Minn H, Knuuti J. PET-tutkimus kliinisessä käytössä. Sairaala 2003:66(3):30-33.

Minn H, *Kööbi T, Ahonen A. Lyhytikäiset isotoopit syöpätautien diagnostiikassa. Duodecim 2003:119:26-32.

*Mäkelä T, *Pham QC, *Clarysse P, *Nenonen J, *Lötjönen J, *Sipilä O, *Hänninen H, *Lauerma K, Knuuti J, *Katila T, *Magnin I. A 3-D model-based registration approach for the PET, MR and MCG cardiac data fusion. MEDICAL IMAGE ANALYSIS 2003:7:377-389. IF [2,680]

*Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, Rinne JO. Progression of dopaminergic hypofunction in striatal subregions in Parkinson´s disease using 18F-CFT PET. Synapse 2003:48:109-115. IF [2,631]

Någren K. PET and knockout mice in drug discovery. DRUG DISCOVERY TODAY 2003:8(19):876. IF [4,416]

Raitakari OT, Juonala M, *Kähönen M, *Taittonen L, *Laitinen T, *Mäki-Torkko N, Järvisalo MJ, *Uhari MU, *Jokinen E, Rönnemaa T, *Åkerblom HK, Viikari JSA. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood. The cardiovascular risk in young Finns study. JAMA 2003:290(17):2277-2283. IF [16,586]

*Renvall K, Laine M, *Hiltunen J, Rinne J, Kaasinen V, *Sipilä H, *Cornelissen K, *Martin N. Naming of multiple objects: neural correlates as measured by positron emission tomography. Appl Neuropsychol 2003:10:224-.

Rinne J. Uutta Alzheimerin taudista. Erikoislääkäri 2003:4:159.

Rinne J. Endogenous dopamine release in Parkinson's disease. Lancet 2003:2:460-461. IF [15,397]

Rinne J, Laine M, *Hiltunen J, *Erkinjuntti T. Semantic decision making in early probable AD: a PET activation study. Cognitive Brain Res 2003:18:89-96. IF [2,404]

Rinne J, Oikonen V, *Teräs M, Hietala J. Aivojen PET-tutkimukset - kliinisiä sovelluksia. Kirjassa: Sovijärvi A, Ahonen A, Hartiala J, Länsimies E, Savolainen S, Turjanmaa V, Vanninen E, toim. Kliininen fysiologia ja isotooppilääketiede, s. 80-87. Helsinki: Kustannus Oy Duodecim, 2003.

Rinne J, *Ulmanen I, *Lee M-S. Catechol-0-methyl transferase (COMT) inhibitors in patients with Parkinson's disease. AMERICAN JOURNAL OF PHARMACOGENOMICS 2003:3:11-15.

Rinne JO, Kaasinen V, Järvenpää T, Någren K, Roivainen A, *Yu M, Oikonen V, Kurki T. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003:74:113-115. IF [2,939]

Roivainen A, *Parkkola R, *Yli-Kerttula T, Lehikoinen P, Viljanen T, *Möttönen T, Nuutila P, Minn H. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 2003:48(11):3077-3084. IF [7,379]

*Räsänen JV, *Sihvo E, Knuuti J, Minn H, *Luostarinen M, *Laippala P, Viljanen T, *Salo J. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. ANNALS OF SURGICAL ONCOLOGY 2003:10(8):954-960. IF [3,308]

*Schelbert HR, *Beanlands R, *Bengel F, Knuuti J, *Dicarli M, *Machac J, *Patterson R. PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting. J Nucl Cardiol. 2003 ;10(5):557-571. IF [1,167].

Stolen K, Kemppainen J, Kalliokoski K, Luotolahti M, Viljanen T, Nuutila P, Knuuti J. Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy. J Nucl Cardiol 2003:10:447-455. IF [1,167]

Stolen KQ, Kemppainen J, Ukkonen H, Kalliokoski KK, Luotolahti M, Lehikoinen P, *Hämäläinen H, *Salo T, Airaksinen KEJ, Nuutila P, Knuuti J. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003:41(3):460-467. IF [6,278]

Sundell J, Huupponen R, Raitakari O, Nuutila P, Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res 2003:11(6):776-782. IF [3,025]

Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res 2003:57:312-319. IF [4,692]

Sundell J, Laine H, Luotolahti M, Nuutila P, Kalliokoski K, Raitakari O, Knuuti J. Blunted coronary vasoreactivity to insulin is an early alternation in hypertension. J Vasc Res 2003:40:58-67. IF [2,458]

Sutinen E, Jyrkkiö S, *Alanen K, Någren K, Minn H. Uptake of (N-methyl-11C)alfa-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med 2003:30:72-77. IF [3,464]

*Tárkányi F, *Takács S, *Hermanne A, *Ditrói F, *Andó L, Heseliu S-J, Bergman J. New experimental data on excitation functions for practical applications of alpha induced nuclear reactions on Ta up to 30 MeV. Nucl. Instr. and Meth. 2003:B211 IF [1,041]

*Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H. Evaluation of brain tumor metabolism with [11C] choline PET and 1H-MRS. J Neurooncol 2003:62(3):329-38. IF [1,416]

Virtanen KA, Hällsten K, *Parkkola R, Janatuinen T, *Lönnqvist F, Viljanen T, Rönnemaa T, Knuuti J, Huupponen R, *Lönnroth P, Nuutila P. Differential effects of rosiglitazone and Metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes (NY) 2003:52:283-290. IF [8,256]

*Yu M, Någren K, *Chen I, *Livni E, *Elmaleh D, *Kozikowski A, *Wang X, *Jokivarsi K, *Brownell A-L. Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-1-(methylamino) bicyclo (2.1.1)-hexane -5-carboxylate, a potential neuroprotective drug. Life Sci 2003:73:1577-1585. IF [1,824]